You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited.
Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication.
The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
In June 2020, the Australia New Zealand Marine Biotechnology Society (ANZMBS) became affiliated to Marine Drugs and the Journal of Marine Science and Engineering (JMSE). As part of this collaboration, all members of ANZMBS enjoy a discount on the article processing charges (APC) when submitting articles to these two journals.
The Australia New Zealand Marine Biotechnology Society (ANZMBS) aims to be the primary voice of advocacy and representation for all aspects of marine biotechnology in Australia and New Zealand through developing and engaging in collaborations between scientists, technologists, investors, government, industry and community; informing educators and policy makers; and organizing activities for the enhancement of science and exchange of knowledge and technology.
ANZMBS is a professional organization whose functions are highly relevant to the scope of Marine Drugs and JMSE. We look forward to collaborating with ANZMBS and publishing state-of-the-art research from its members in this field.